Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases.
Li XL, Tang JF, Li WX, Li CX, Zhao T, Zhao BC, Wang Y, Zhang H, Chen XF, Xu T, Zhu MJ.
Li XL, et al. Among authors: li wx, li cx.
Evid Based Complement Alternat Med. 2015;2015:610846. doi: 10.1155/2015/610846. Epub 2015 Oct 5.
Evid Based Complement Alternat Med. 2015.
PMID: 26508981
Free PMC article.